Jupiter Asset Management Ltd. acquired a new stake in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 8,826 shares of the company's stock, valued at approximately $527,000.
A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Blueshift Asset Management LLC bought a new position in shares of Astera Labs during the first quarter valued at $724,000. Jefferies Financial Group Inc. bought a new position in shares of Astera Labs during the first quarter valued at $1,392,000. Harbour Investments Inc. lifted its holdings in shares of Astera Labs by 351.7% during the first quarter. Harbour Investments Inc. now owns 795 shares of the company's stock valued at $47,000 after acquiring an additional 619 shares during the period. XTX Topco Ltd lifted its holdings in shares of Astera Labs by 1,326.7% during the first quarter. XTX Topco Ltd now owns 37,307 shares of the company's stock valued at $2,226,000 after acquiring an additional 34,692 shares during the period. Finally, Banque Cantonale Vaudoise bought a new position in shares of Astera Labs during the first quarter valued at $161,000. 60.47% of the stock is owned by institutional investors.
Analysts Set New Price Targets
ALAB has been the subject of a number of analyst reports. Wall Street Zen cut Astera Labs from a "buy" rating to a "hold" rating in a report on Saturday, July 12th. Evercore ISI raised their target price on Astera Labs from $87.00 to $104.00 and gave the company an "outperform" rating in a research note on Wednesday, May 21st. Needham & Company LLC lowered their target price on Astera Labs from $140.00 to $100.00 and set a "buy" rating for the company in a research note on Wednesday, May 7th. Northland Securities lowered Astera Labs from an "outperform" rating to a "market perform" rating and set a $120.00 target price for the company. in a research note on Tuesday, July 22nd. Finally, Citigroup lowered their target price on Astera Labs from $120.00 to $100.00 and set a "buy" rating for the company in a research note on Monday, April 14th. Four investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $106.73.
Read Our Latest Research Report on Astera Labs
Insider Transactions at Astera Labs
In other news, CEO Jitendra Mohan sold 128,250 shares of the business's stock in a transaction dated Monday, May 19th. The stock was sold at an average price of $90.02, for a total transaction of $11,545,065.00. Following the completion of the transaction, the chief executive officer directly owned 541,125 shares in the company, valued at approximately $48,712,072.50. The trade was a 19.16% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Michael Truett Tate sold 500,000 shares of the business's stock in a transaction dated Friday, May 30th. The stock was sold at an average price of $90.23, for a total value of $45,115,000.00. Following the transaction, the chief financial officer owned 618,996 shares of the company's stock, valued at $55,852,009.08. The trade was a 44.68% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 2,181,759 shares of company stock worth $200,883,431.
Astera Labs Stock Up 5.2%
Shares of ALAB stock opened at $137.93 on Tuesday. The stock has a 50-day moving average price of $100.36 and a 200 day moving average price of $85.78. The firm has a market cap of $22.75 billion, a price-to-earnings ratio of 626.98, a PEG ratio of 6.15 and a beta of 1.39. Astera Labs, Inc. has a 12 month low of $36.22 and a 12 month high of $147.39.
Astera Labs (NASDAQ:ALAB - Get Free Report) last announced its quarterly earnings data on Tuesday, May 6th. The company reported $0.33 EPS for the quarter, topping analysts' consensus estimates of $0.28 by $0.05. The firm had revenue of $159.44 million during the quarter, compared to analyst estimates of $151.55 million. Astera Labs had a return on equity of 2.57% and a net margin of 8.44%. The company's revenue was up 144.1% on a year-over-year basis. During the same period last year, the company earned $0.10 earnings per share. Sell-side analysts predict that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.
About Astera Labs
(
Free Report)
Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Astera Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.
While Astera Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.